Hologic Net Working Capital Over Time
| HOLX Stock | USD 79.50 0.06 0.08% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Hologic Performance and Hologic Correlation. Hologic |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.116 | Earnings Share 3.32 | Revenue Per Share 16.715 | Quarterly Revenue Growth 0.045 | Return On Assets 0.0645 |
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Working Capital Analysis
Compare Hologic and related stocks such as Haemonetics, ICU Medical, and Envista Holdings Corp Net Working Capital Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HAE | 136.5 M | 136.5 M | 136.5 M | 136.5 M | 136.5 M | 136.5 M | 136.5 M | 136.5 M | 340.4 M | 328.8 M | 440.1 M | 313.8 M | 517.9 M | 468.5 M | 400.1 M |
| ICUI | 654.4 M | 654.4 M | 654.4 M | 654.4 M | 654.4 M | 654.4 M | 654.4 M | 654.4 M | 677.7 M | 633.7 M | 725.3 M | 829 M | 740.6 M | 739.4 M | 785.8 M |
| NVST | 166.3 M | 166.3 M | 166.3 M | 166.3 M | 166.3 M | 166.3 M | 166.3 M | 166.3 M | 145.8 M | 292.7 M | (94.2 M) | 628 M | 187.9 M | 962.9 M | 1 B |
| COO | 557.1 M | 557.1 M | 557.1 M | 557.1 M | 557.1 M | 557.1 M | 557.1 M | 554.4 M | 52.8 M | 269.8 M | 733.2 M | 253.4 M | 735.9 M | 846.3 M | 496 M |
| WST | 464 M | 464 M | 464 M | 464 M | 464 M | 464 M | 464 M | 464 M | 610.7 M | 717.1 M | 870.3 M | 1.1 B | 1.4 B | 1.3 B | 1 B |
| TFX | 644.9 M | 644.9 M | 644.9 M | 644.9 M | 644.9 M | 644.9 M | 644.9 M | 644.9 M | 653.7 M | 743.3 M | 882.4 M | 749 M | 829.5 M | 800.7 M | 833.4 M |
| ALC | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 119 M | 1.9 B | 2.7 B | 2.9 B | 2.4 B | 3.2 B | 2.3 B |
| RMD | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 554.5 M | 589.4 M | 920.7 M | 663 M | 1.2 B | 1.6 B | 1.4 B | 1.1 B |
| BDX | 15.3 B | 15.3 B | 15.3 B | 15.3 B | 15.3 B | 15.3 B | 15.3 B | 195 M | 1 B | 3.1 B | 2.2 B | 330 M | 2 B | 1.8 B | 2.8 B |
| MMSI | 200.5 M | 200.5 M | 200.5 M | 200.5 M | 200.5 M | 200.5 M | 200.5 M | 200.5 M | 254.5 M | 272.9 M | 244.7 M | 245.9 M | 308.4 M | 904.9 M | 950.2 M |
| ANGO | 82.4 M | 82.4 M | 82.4 M | 82.4 M | 82.4 M | 82.4 M | 82.4 M | 110.7 M | 242 M | 101.5 M | 83.3 M | 69 M | 79.7 M | 102.1 M | 87.1 M |
| ATR | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 641.6 M | 608 M | 588.7 M | 375.7 M | 513.1 M | 298 M | 476.3 M |
Hologic and related stocks such as Haemonetics, ICU Medical, and Envista Holdings Corp Net Working Capital description
My Equities
My Current Equities and Potential Positions
| Hologic | HOLX |
| Classification | Obamacare Repeal |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 79.5
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.